NCT05498090View on ClinicalTrials.gov

Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males with Klinefelter Syndrome

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 3, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

August 30, 2025

Conditions
Klinefelter Syndrome
Interventions
DRUG

Fenofibrate 145 mg

Fenofibrate 145 mg PO daily for 4 weeks

Trial Locations (1)

80045

University of Colorado - Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Colorado, Denver

OTHER